Fintel reports that on January 29, 2025, Cantor Fitzgerald upgraded their outlook for Beam Therapeutics (NasdaqGS:BEAM) from ...

Cantor Fitzgerald upgraded shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a neutral rating to an overweight rating in a research note published on Wednesday morning, Marketbeat reports.

In the preceding three months, 4 analysts have released ratings for Beam Therapeutics (NASDAQ:BEAM), presenting a wide array of perspectives from bullish to bearish. The following table summarizes ...

Grayscale, known for its Bitcoin and Ethereum spot ETFs, has now launched a Dogecoin trust—and filed to convert it into a ...

The One Beam with it’s ease of use and it’s remarkable precision, gives the precise information on bilirubin levels and support which the Doctors need. The One Beam allows for a rapid photo ...

Headlight glare giving you a headache? We talked to automotive experts to get the inside scoop on why cars seem brighter than ...

SteelAsia Manufacturing Corp., the Philippines’ leading steel producer, marked a significant milestone on Jan. 30, 2025, with ...

We tested four super bright flashlights that range from a laser-powered flashlight that shoots a beam over a .5 mile to a ...

It’s National Data Privacy Week, which the Federal Privacy Council says is a time to talk about “respecting privacy, ...

Welcome to our review of the Jetbeam E26-UV Kunai, a perfectly formed aluminium-clad pocket torch with some exceptional ...